GO:0005525 | GTP binding | 7.01e-05 | 6.84e-01 | 4.046 | 4 | 12 | 197 |
GO:0004832 | valine-tRNA ligase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0052565 | response to defense-related host nitric oxide production | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0033688 | regulation of osteoblast proliferation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0008074 | guanylate cyclase complex, soluble | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0010467 | gene expression | 3.10e-03 | 1.00e+00 | 2.605 | 4 | 49 | 535 |
GO:0070006 | metalloaminopeptidase activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0010815 | bradykinin catabolic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0060087 | relaxation of vascular smooth muscle | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0043931 | ossification involved in bone maturation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0002181 | cytoplasmic translation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 3 | 6 |
GO:0004383 | guanylate cyclase activity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0043297 | apical junction assembly | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0003924 | GTPase activity | 8.97e-03 | 1.00e+00 | 3.774 | 2 | 7 | 119 |
GO:0010388 | cullin deneddylation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 4 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0043296 | apical junction complex | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0000398 | mRNA splicing, via spliceosome | 1.03e-02 | 1.00e+00 | 3.668 | 2 | 15 | 128 |
GO:0006184 | GTP catabolic process | 1.06e-02 | 1.00e+00 | 3.646 | 2 | 7 | 130 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 10 |
GO:0001054 | RNA polymerase I activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0006182 | cGMP biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0007263 | nitric oxide mediated signal transduction | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 13 |
GO:0050772 | positive regulation of axonogenesis | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0008380 | RNA splicing | 1.68e-02 | 1.00e+00 | 3.302 | 2 | 21 | 165 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 3 | 14 |
GO:0006386 | termination of RNA polymerase III transcription | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 14 |
GO:0004177 | aminopeptidase activity | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 3 | 14 |
GO:0000188 | inactivation of MAPK activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 4 | 15 |
GO:0032467 | positive regulation of cytokinesis | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 16 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 18 |
GO:0006378 | mRNA polyadenylation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 18 |
GO:0005856 | cytoskeleton | 2.19e-02 | 1.00e+00 | 3.099 | 2 | 8 | 190 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 19 |
GO:0008180 | COP9 signalosome | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 6 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 5 | 24 |
GO:0030145 | manganese ion binding | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 3 | 26 |
GO:0051496 | positive regulation of stress fiber assembly | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 4 | 27 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 6 | 29 |
GO:0032154 | cleavage furrow | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 3 | 30 |
GO:0008015 | blood circulation | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 1 | 31 |
GO:0021762 | substantia nigra development | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0007266 | Rho protein signal transduction | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 35 |
GO:0050434 | positive regulation of viral transcription | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 5 | 35 |
GO:0030334 | regulation of cell migration | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 36 |
GO:0003743 | translation initiation factor activity | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 8 | 37 |
GO:0006396 | RNA processing | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 6 | 40 |
GO:0008217 | regulation of blood pressure | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 2 | 42 |
GO:0005829 | cytosol | 5.20e-02 | 1.00e+00 | 1.187 | 5 | 88 | 1787 |
GO:0032481 | positive regulation of type I interferon production | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 48 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 8 | 52 |
GO:0007596 | blood coagulation | 6.30e-02 | 1.00e+00 | 2.263 | 2 | 13 | 339 |
GO:0045666 | positive regulation of neuron differentiation | 6.33e-02 | 1.00e+00 | 3.941 | 1 | 3 | 53 |
GO:0006289 | nucleotide-excision repair | 6.33e-02 | 1.00e+00 | 3.941 | 1 | 6 | 53 |
GO:0071013 | catalytic step 2 spliceosome | 7.25e-02 | 1.00e+00 | 3.738 | 1 | 5 | 61 |
GO:0005923 | tight junction | 7.59e-02 | 1.00e+00 | 3.668 | 1 | 2 | 64 |
GO:0005654 | nucleoplasm | 8.58e-02 | 1.00e+00 | 1.479 | 3 | 68 | 876 |
GO:0030496 | midbody | 8.62e-02 | 1.00e+00 | 3.479 | 1 | 6 | 73 |
GO:0001649 | osteoblast differentiation | 8.73e-02 | 1.00e+00 | 3.459 | 1 | 5 | 74 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 8.95e-02 | 1.00e+00 | 3.421 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 9.07e-02 | 1.00e+00 | 3.402 | 1 | 6 | 77 |
GO:0016032 | viral process | 9.46e-02 | 1.00e+00 | 1.927 | 2 | 30 | 428 |
GO:0030529 | ribonucleoprotein complex | 9.63e-02 | 1.00e+00 | 3.311 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 9.74e-02 | 1.00e+00 | 3.293 | 1 | 2 | 83 |
GO:0030027 | lamellipodium | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 3 | 88 |
GO:0020037 | heme binding | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 3 | 88 |
GO:0030036 | actin cytoskeleton organization | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 4 | 90 |
GO:0006413 | translational initiation | 1.15e-01 | 1.00e+00 | 3.039 | 1 | 6 | 99 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 2 | 108 |
GO:0007049 | cell cycle | 1.33e-01 | 1.00e+00 | 2.823 | 1 | 8 | 115 |
GO:0004872 | receptor activity | 1.34e-01 | 1.00e+00 | 2.810 | 1 | 4 | 116 |
GO:0030168 | platelet activation | 1.60e-01 | 1.00e+00 | 2.529 | 1 | 5 | 141 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.81e-01 | 1.00e+00 | 2.338 | 1 | 18 | 161 |
GO:0005739 | mitochondrion | 1.92e-01 | 1.00e+00 | 1.304 | 2 | 32 | 659 |
GO:0007264 | small GTPase mediated signal transduction | 1.94e-01 | 1.00e+00 | 2.225 | 1 | 8 | 174 |
GO:0006412 | translation | 1.98e-01 | 1.00e+00 | 2.193 | 1 | 12 | 178 |
GO:0005737 | cytoplasm | 2.01e-01 | 1.00e+00 | 0.628 | 5 | 127 | 2633 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.19e-01 | 1.00e+00 | 2.032 | 1 | 8 | 199 |
GO:0006281 | DNA repair | 2.23e-01 | 1.00e+00 | 2.003 | 1 | 24 | 203 |
GO:0030054 | cell junction | 2.37e-01 | 1.00e+00 | 1.900 | 1 | 5 | 218 |
GO:0007411 | axon guidance | 2.55e-01 | 1.00e+00 | 1.780 | 1 | 8 | 237 |
GO:0007155 | cell adhesion | 2.62e-01 | 1.00e+00 | 1.738 | 1 | 8 | 244 |
GO:0003723 | RNA binding | 2.65e-01 | 1.00e+00 | 1.720 | 1 | 22 | 247 |
GO:0006508 | proteolysis | 2.80e-01 | 1.00e+00 | 1.624 | 1 | 11 | 264 |
GO:0005925 | focal adhesion | 2.97e-01 | 1.00e+00 | 1.529 | 1 | 14 | 282 |
GO:0005524 | ATP binding | 3.01e-01 | 1.00e+00 | 0.868 | 2 | 37 | 892 |
GO:0009986 | cell surface | 3.05e-01 | 1.00e+00 | 1.484 | 1 | 5 | 291 |
GO:0070062 | extracellular vesicular exosome | 3.27e-01 | 1.00e+00 | 0.573 | 3 | 51 | 1641 |
GO:0003677 | DNA binding | 3.27e-01 | 1.00e+00 | 0.781 | 2 | 52 | 947 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.47e-01 | 1.00e+00 | 1.255 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 3.56e-01 | 1.00e+00 | 1.209 | 1 | 14 | 352 |
GO:0005515 | protein binding | 3.95e-01 | 1.00e+00 | 0.244 | 6 | 198 | 4124 |
GO:0042803 | protein homodimerization activity | 4.16e-01 | 1.00e+00 | 0.927 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 4.34e-01 | 1.00e+00 | 0.848 | 1 | 12 | 452 |
GO:0016020 | membrane | 4.47e-01 | 1.00e+00 | 0.431 | 2 | 56 | 1207 |
GO:0007165 | signal transduction | 5.44e-01 | 1.00e+00 | 0.397 | 1 | 24 | 618 |
GO:0005634 | nucleus | 6.04e-01 | 1.00e+00 | 0.004 | 4 | 158 | 3246 |
GO:0044822 | poly(A) RNA binding | 6.41e-01 | 1.00e+00 | 0.026 | 1 | 45 | 799 |
GO:0005886 | plasma membrane | 6.73e-01 | 1.00e+00 | -0.132 | 2 | 46 | 1784 |
GO:0005730 | nucleolus | 7.98e-01 | 1.00e+00 | -0.581 | 1 | 74 | 1217 |